NPR covers new brain mapping technology that enables neurosurgeons to precisely remove diseased brain tissue while preserving functions important to individual patients in real time during surgery. Ahmed Raslan, M.D., says, “If somebody is a mathematician, we’ll give them a math formula. If somebody is a painter, we’ll give them what’s called a visual cognition task.”

KPTV-TV covers new OHSU program that enables parents to hold and bond with their babies in the neonatal intensive care unit sooner, a program that’s the first of its kind.

The OHSU Foundation will receive $275,000 as part of nationwide settlement with Johnson & Johnson over deceptive marketing to fund an outreach cancer screening van for tribal communities.

The OHSU Foundation will receive $275,000 as part of nationwide settlement with Johnson & Johnson over deceptive marketing to fund an outreach cancer screening van for tribal communities.

The OHSU Foundation will receive $275,000 as part of nationwide settlement with Johnson & Johnson over deceptive marketing to fund an outreach cancer screening van for tribal communities.

The OHSU Foundation will receive $275,000 as part of nationwide settlement with Johnson & Johnson over deceptive marketing to fund an outreach cancer screening van for tribal communities.

The OHSU Foundation will receive $275,000 as part of nationwide settlement with Johnson & Johnson over deceptive marketing to fund an outreach cancer screening van for tribal communities.

The OHSU Foundation will receive $275,000 as part of nationwide settlement with Johnson & Johnson over deceptive marketing to fund an outreach cancer screening van for tribal communities.

Nima Nabavizadeh, M.D., provides expert commentary on multi-cancer early detection, or MCED, tests that are designed to screen for more than 50 types of cancer via a blood test.

Healio interviews Maria Fleseriu, M.D., regarding a clinical trial involving a new therapy for people with Cushing’s disease, diabetes and hypertension. She says, “This study highlights the need to adjust medications for comorbidities such as hypertension and diabetes after treatment for Cushing’s disease as improvement is expected in most but not all patients.”